American National Bank & Trust Co. VA Takes Position in Chemed Co. (NYSE:CHE)

American National Bank & Trust Co. VA purchased a new stake in shares of Chemed Co. (NYSE:CHE) in the first quarter, according to its most recent filing with the SEC. The firm purchased 4,864 shares of the company’s stock, valued at approximately $3,122,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Wellington Management Group LLP lifted its position in shares of Chemed by 0.3% during the 3rd quarter. Wellington Management Group LLP now owns 386,237 shares of the company’s stock valued at $200,727,000 after acquiring an additional 1,044 shares during the period. JPMorgan Chase & Co. raised its position in shares of Chemed by 9.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 287,386 shares of the company’s stock worth $149,355,000 after purchasing an additional 24,161 shares during the last quarter. TD Asset Management Inc raised its position in shares of Chemed by 164.3% during the 4th quarter. TD Asset Management Inc now owns 205,777 shares of the company’s stock worth $120,328,000 after purchasing an additional 127,934 shares during the last quarter. Massachusetts Financial Services Co. MA raised its position in shares of Chemed by 121.5% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 203,096 shares of the company’s stock worth $118,760,000 after purchasing an additional 111,399 shares during the last quarter. Finally, Victory Capital Management Inc. raised its position in shares of Chemed by 19.7% during the 4th quarter. Victory Capital Management Inc. now owns 188,679 shares of the company’s stock worth $110,330,000 after purchasing an additional 31,036 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Price Performance

CHE traded down $1.68 during trading on Thursday, hitting $540.00. The company’s stock had a trading volume of 76,198 shares, compared to its average volume of 93,278. The firm’s 50 day moving average price is $552.98 and its 200-day moving average price is $588.21. The stock has a market cap of $8.18 billion, a PE ratio of 29.06, a PEG ratio of 2.23 and a beta of 0.43. Chemed Co. has a twelve month low of $492.84 and a twelve month high of $654.62.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Wednesday, April 24th. The company reported $4.68 earnings per share for the quarter, missing the consensus estimate of $5.09 by ($0.41). The business had revenue of $589.23 million during the quarter, compared to analyst estimates of $587.18 million. Chemed had a net margin of 12.36% and a return on equity of 30.52%. Equities analysts anticipate that Chemed Co. will post 21.54 earnings per share for the current year.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 18th. Shareholders of record on Thursday, May 30th were issued a $0.40 dividend. The ex-dividend date was Thursday, May 30th. This represents a $1.60 annualized dividend and a yield of 0.30%. Chemed’s dividend payout ratio (DPR) is presently 8.61%.

Insider Buying and Selling at Chemed

In other news, CEO Kevin J. Mcnamara sold 4,000 shares of the business’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $567.54, for a total transaction of $2,270,160.00. Following the completion of the sale, the chief executive officer now directly owns 108,549 shares of the company’s stock, valued at approximately $61,605,899.46. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, CEO Kevin J. Mcnamara sold 4,000 shares of the business’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $567.54, for a total transaction of $2,270,160.00. Following the completion of the sale, the chief executive officer now directly owns 108,549 shares of the company’s stock, valued at approximately $61,605,899.46. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Kevin J. Mcnamara sold 1,500 shares of the business’s stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $544.17, for a total transaction of $816,255.00. Following the sale, the chief executive officer now directly owns 107,049 shares of the company’s stock, valued at $58,252,854.33. The disclosure for this sale can be found here. In the last three months, insiders sold 5,784 shares of company stock worth $3,240,053. Insiders own 3.32% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently issued reports on CHE shares. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, May 4th. Royal Bank of Canada cut their price objective on Chemed from $712.00 to $697.00 and set an “outperform” rating for the company in a research report on Tuesday, May 21st.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.